🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the effect of remote ischemic con...
Status
Unknown
Location
First Hospital of Jilin University
Start Date
2023-08-02
Trial ID
NCT05970653
Treatments Being Tested
The purpose of this study is to find out what combination of components, if...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-12-02
Trial ID
NCT06785064
The purpose of this study is to determine whether remote ischemic condition...
Status
Unknown
Location
Dept. of Renal Medicine, Aarhus University Hospital, Skejby
Start Date
2011-06
Trial ID
NCT01395719
Treatments Being Tested
This randomized, double-blind, sham-controlled trial aims to evaluate the e...
Status
Not Yet Recruiting
Location
Nanjing Brain Hospital
Start Date
2026-04-01
Trial ID
NCT07317557
This is a pilot randomised control trial to assess the safety, compliance, ...
Status
Completed
Location
Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Start Date
2019-02-04
Trial ID
NCT03794947
Treatments Being Tested
This study is a multicenter, prospective, randomized, open-label, parallel-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-10
Trial ID
NCT07562477
Treatments Being Tested
Unilateral cerebral palsy (UCP) is a leading cause of childhood disability....
Status
Completed
Location
Dept. of Physical Therapy, East Carolina University
Start Date
2021-12-18
Trial ID
NCT05355883
The purpose of this study is to evaluate the effects of remote ischemic con...
Status
Completed
Location
Seoul National University Hospital
Start Date
2017-05-11
Trial ID
NCT03125681
Treatments Being Tested
The primary objective of the study will be to determine whether rapid remot...
Status
Completed
Location
Xuanwu Hospital, Capital Medical University
Start Date
2021-12-01
Trial ID
NCT05023941
Treatments Being Tested
Progressive MS remains the most difficult therapeutic challenge. Remyelinat...
Status
Not Yet Recruiting
Location
University of Calgary
Start Date
2024-07-01
Trial ID
NCT06171334
Treatments Being Tested